Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026

Contributed by: ACCESS Newswire

Logo

Tags

Gedeon Richter Plc.

Healthcare & Pharmaceutical

OTC PINK:RGEDF

Company Update

More Like This

Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care

PR Newswire associated0

"Gedeon Richter House of Hope" opens its doors to support 300 women annually in Africa-Bamako

Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers

Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars

InterAx Biotech gibt den Erhalt einer äußerst wettbewerbsorientierten europäischen Förderung zur Finanzierung seiner Arzneimittelentwicklung bekannt und informiert über wichtige Finanzdaten

Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market

PR Newswire associated0

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars

Sobi to share new clinical data and research at EULAR 2025